V710 + MAA

V710 + MAA is a **combination vaccine candidate** consisting of the V710 vaccine (targeting *Staphylococcus aureus*) administered with MAA (most commonly referring to "Aluminum adjuvant," though exact identity should be verified in original study context). V710 is a therapeutic vaccine developed to stimulate an immune response against *Staphylococcus aureus* infection. The addition of MAA as an adjuvant is intended to enhance the immunogenicity of the vaccine[1]. Trials of V710 + MAA investigated its ability to prevent various serious staphylococcal infections (e.g., bacteremia, mediastinitis). The combination was studied up to Phase 3, but development appears discontinued[1].